Patent Assignment
Reel/Frame 061393/0881
Assignment of Assignor's Interest
Recorded: 2022-10-12
Pages: 6
Assignors
YAO, YIHONG
Executed: 2022-09-21
ZHU, LIN
Executed: 2022-09-21
LI, YANFENG
Executed: 2022-09-21
WEI, YUTIAN
Executed: 2022-09-21
YAO, XIN
Executed: 2022-09-21
ZHU, SHIGUI
Executed: 2022-09-21
HUANG, JIAQI
Executed: 2022-09-21
ZHANG, LI
Executed: 2022-10-09
Assignees
SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
BUILDING 3, 85 FALADI ROAD, CHINA (SHANGHAI) PILOT FREE TRADE ZONE, PUDONG NEW AREA, SHANGHAI, 201210, CHINA
WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
1ST FL. A AREA, 2ND FL. A AREA, 2ND FL. B AREA, BUILDING 7, 1699 HUISHAN ROAD, HUISHAN DISTRICT, WUXI, JIANGSU, 214174, CHINA
Covered Property
(1)
CD22-Targeted Chimeric Antigen Receptor, Preparation Method Therefor and Application Thereof
Application:
17/918,414 →
Publication:
US 2023/0144447
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Apr 16, 2024
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067128/0044 →
Assignment of Assignor's Interest
May 1, 2024
From: WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067282/0585 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 67128 Frame: 44. Assignor(S) Hereby Confirms the Change of Name.
May 7, 2024
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067334/0083 →